Starbucks is ending GLP-1 coverage for weight loss as employer costs climb

Marcin Golba/NurPhoto via Getty Images In October, Starbucks will stop covering GLP-1 drugs prescribed for weight loss for benefits-eligible employees. The move comes as GLP-1 drugs consume a growing share of employers' healthcare spending. While some employers retreat from coverage, Bank of America is spending heavily to keep the benefit. Starbucks is pulling back coverage for weight-loss drugs, a reversal that comes as employers' spending on popular GLP-1 medicines soars. Starting in…